Meghan Good serves as Associate Director at Cybin Inc since October 2023, focusing on the development of psychedelic treatments for mental health disorders, emphasizing clinical pharmacology, pharmacokinetics, and data analysis while collaborating with multi-disciplinary teams. Previously, Meghan held the position of Research Manager at Small Pharma, overseeing preclinical studies and statistical analysis for psychedelic-assisted psychotherapy targeting major depressive disorder. Additional experience includes roles as a Clinical Project Manager at Small Pharma, Research Project Assistant at BioBeats, Consultant at Anmut, Research Assistant at Guy's and St Thomas' NHS Foundation Trust, and Research Intern at both the University of Bristol and The University of Manchester. Meghan holds a Master's degree in Experimental Neuroscience from Imperial College London and a Bachelor's degree in Neuroscience from the University of Bristol.
This person is not in any teams
This person is not in any offices